| Literature DB >> 15799960 |
Adrienne E Dubin1, Nadia Nasser, Jutta Rohrbacher, An N Hermans, Roger Marrannes, Christopher Grantham, Koen Van Rossem, Miroslav Cik, Sandra R Chaplan, David Gallacher, Jia Xu, Antonio Guia, Nicholas G Byrne, Chris Mathes.
Abstract
The authors used the PatchXpress 7000A system to measure compound activity at the hERG channel using procedures that mimicked the "gold-standard" conventional whole-cell patch clamp. A set of 70 compounds, including hERG antagonists with potencies spanning 3 orders of magnitude, were tested on hERG302-HEK cells using protocols aimed at either identifying compound activity at a single concentration or obtaining compound potency from a cumulative concentration dependence paradigm. After exposure to compounds and subsequent washout of the wells to determine reversibility of the block, blockade by a reference compound served as a quality control. Electrical parameters and voltage dependence were similar to those obtained using a conventional whole-cell patch clamp. Rank order of compound potency was also comparable to that determined by conventional methods. One exception was flunarizine, a particularly lipophilic compound. The PatchXpress accurately identified the activity of 29 moderately potent antagonists, which only weakly displace radiolabeled astemizole and are false negatives in the binding assay. Finally, no false hits were observed from a collection of relatively inactive compounds. High-quality data acquisition by PatchXpress should help accelerate secondary screening for ion channel modulators and the drug discovery process.Entities:
Mesh:
Substances:
Year: 2005 PMID: 15799960 DOI: 10.1177/1087057104272295
Source DB: PubMed Journal: J Biomol Screen ISSN: 1087-0571